Skip to main content
Top

30-04-2024 | ECMO | CORRESPONDENCE

ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension

Authors: Hosam F. Ahmed, David L. S. Morales, Don Hayes Jr.

Published in: Lung

Login to get access

Abstract

Idiopathic pulmonary arterial hypertension (IPAH) represents an important clinical indication for lung transplant (LTx) in children. Recent trends show fewer children with IPAH are undergoing LTx nowadays compared to previous time periods, including those with most severe form of the disease. Using the UNOS Registry, we investigated if ECMO at the time of transplant impacts post-transplant survival in children with IPAH. A total of 74 LTx recipients while on ECMO at the time of transplant were identified (IPAH: N = 12). Children with IPAH who underwent LTx while on ECMO had shown comparable survival rates to those who were on ECMO for other conditions. This analysis provides encouraging results, supporting the potential expansion of LTx for this patient population. Given the low number of children undergoing LTx, we think there should be a consensus document to provide better guidance for referring and selecting the high-risk pediatric population with IPAH on ECMO for lung transplant.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hubbard R, Miller R, Tumin D, Tobias JD, Hayes D Jr (2019) Transplant outcomes for idiopathic pulmonary hypertension in children. J Heart Lung Transplant 38(5):580–581CrossRefPubMed Hubbard R, Miller R, Tumin D, Tobias JD, Hayes D Jr (2019) Transplant outcomes for idiopathic pulmonary hypertension in children. J Heart Lung Transplant 38(5):580–581CrossRefPubMed
2.
go back to reference Hayes D Jr, Cherikh WS, Harhay MO, Perch M, Hsich E, Potena L, Sadavarte A, Zehner A, Singh TP, Zuckermann A, Stehlik J (2022) The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-fifth pediatric lung transplantation report—2022; focus on pulmonary vascular diseases. J Heart Lung Transplant 41(10):1348–1356CrossRefPubMedPubMedCentral Hayes D Jr, Cherikh WS, Harhay MO, Perch M, Hsich E, Potena L, Sadavarte A, Zehner A, Singh TP, Zuckermann A, Stehlik J (2022) The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-fifth pediatric lung transplantation report—2022; focus on pulmonary vascular diseases. J Heart Lung Transplant 41(10):1348–1356CrossRefPubMedPubMedCentral
4.
go back to reference Koh W, Zang H, Ollberding NJ, Ziady A, Hayes D Jr (2023) Extracorporeal membrane oxygenation bridge to pediatric lung transplantation: modern era analysis. Pediatr Transplant 27(6):e14570CrossRefPubMed Koh W, Zang H, Ollberding NJ, Ziady A, Hayes D Jr (2023) Extracorporeal membrane oxygenation bridge to pediatric lung transplantation: modern era analysis. Pediatr Transplant 27(6):e14570CrossRefPubMed
5.
go back to reference Maxwell BG, Nies MK, Ajuba-Iwuji CC, Coulson JD, Romer LH (2015) Trends in hospitalization for pediatric pulmonary hypertension. Pediatrics 136(2):241–250CrossRefPubMed Maxwell BG, Nies MK, Ajuba-Iwuji CC, Coulson JD, Romer LH (2015) Trends in hospitalization for pediatric pulmonary hypertension. Pediatrics 136(2):241–250CrossRefPubMed
6.
go back to reference Wijeratne DT, Lajkosz K, Brogly SB, Lougheed MD, Jiang L, Housin A, Barber D, Johnson A, Doliszny KM, Archer SL (2018) Increasing incidence and prevalence of World Health Organization Groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada. Circ Cardiovasc Qual Outcomes 11(2):e003973CrossRefPubMedPubMedCentral Wijeratne DT, Lajkosz K, Brogly SB, Lougheed MD, Jiang L, Housin A, Barber D, Johnson A, Doliszny KM, Archer SL (2018) Increasing incidence and prevalence of World Health Organization Groups 1 to 4 pulmonary hypertension: a population-based cohort study in Ontario, Canada. Circ Cardiovasc Qual Outcomes 11(2):e003973CrossRefPubMedPubMedCentral
Metadata
Title
ECMO Bridge to Lung Transplant in Children with Idiopathic Pulmonary Arterial Hypertension
Authors
Hosam F. Ahmed
David L. S. Morales
Don Hayes Jr.
Publication date
30-04-2024
Publisher
Springer US
Published in
Lung
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-024-00703-4
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine